CAAS Capital Management’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-25,000
Closed -$251K 912
2021
Q2
$251K Hold
25,000
﹤0.01% 514
2021
Q1
$247K Buy
+25,000
New +$247K ﹤0.01% 623